University at Buffalo - The State University of New York
Skip to Content
UBMD Physicians' Group

Clinical Trials

SONAR: Study of Diabetic Nephropathy with Atrasentan. A Randomized, Multi-country, Multi-center, Double-blind, Parallel, Placebo-controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy.

Investigator

Aijaz Gundroo, MD Principal Investigator Rocco C. Venuto, MD Sub-investigator

Contact Information